Engineered extracellular vesicles for ischemic heart diseases: modification methods, targeted delivery strategies, and multi-modal therapies - A systematic review - Poll - MDSpire

Engineered extracellular vesicles for ischemic heart diseases: modification methods, targeted delivery strategies, and multi-modal therapies - A systematic review

  • By

  • Sha Su

  • Yu Teng

  • Shaojiao Liu

  • Lei Wang

  • Mingjing Zhao

  • June 18, 2026

  • 0 min

Share

Original Source(s)

Engineered extracellular vesicles for ischemic heart diseases: modification methods, targeted delivery strategies, and multi-modal therapies - A systematic review

  • by Sha Su, Yu Teng, Shaojiao Liu, Lei Wang, Mingjing Zhao

  • June 18, 2026

Related Content

Invasive NSTEMI Strategy Shows No Benefit in Frail Patients

Frailty severity may identify older patients least likely to benefit—and potentially at higher risk—with invasive management.

Shexiang Tongxin Dropping Pill for Coronary Microvascular Disease: Rationale and Design of a Multicenter Randomized Trial with a Cardiopulmonary Exercise Testing Primary Endpoint and AI-Enhanced Myocardial Contrast Echocardiograph

Limonin Reduces Pyroptosis and Inflammation in Myocardial Ischemia-Reperfusion Mice by Targeting the Caspase-3/GSDME Pathway